Vitamin D deficiency and its association with low bone mineral density, HIV-related factors, hospitalization, and death in a predominantly black HIV-infected cohort

Clinical Infectious Diseases

Volumn 55, Issue 12, 2012, Pages 1727-1736

  Sherwood, Jeffrey E ^a   Mesner, Octavio C ^b   Weintrob, Amy C ^b,c,d   Hadigan, Colleen M ^e   Wilkins, Kenneth J ^b   Crum Cianflone, Nancy F ^b,f   Aronson, Naomi E ^c,d  

^a WILLIAM BEAUMONT ARMY MEDICAL CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

^d Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^f NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALCOHOL; ANTIRETROVIRUS AGENT; EFAVIRENZ; TENOFOVIR;

ADULT; ARTICLE; BONE DENSITY; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; DISEASE COURSE; DUAL ENERGY X RAY ABSORPTIOMETRY; EXERCISE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; VITAMIN D DEFICIENCY;

ABSORPTIOMETRY, PHOTON; ADULT; AFRICAN AMERICANS; BONE DENSITY; CASE-CONTROL STUDIES; FEMALE; HIV INFECTIONS; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MILITARY PERSONNEL; RISK FACTORS; UNITED STATES; VITAMIN D DEFICIENCY;

EID: 84870199243     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis785     Document Type: Article

References (36)

1. Ginde AA, Liu MC, Camargo CA. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009; 169:626-32.
2. Dao CN, Patel P, Overton ET, et al. Low vitamin D among HIVinfected adults: Prevalence of and risk factors for low vitamin D Levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population. Clin Infect Dis 2011; 52:396-405.
3. Madeddu G, Spanu A, Solinas P, et al. Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy. Q J Nucl Med Mol Imaging 2004; 48:39-48.
4. Clay PG, Voss LE, Williams C, Daume EC. Valid treatment options for osteoporosis and osteopenia in HIV-infected persons. Ann Pharmacother 2008; 42:670-9. (Pubitemid 351619938)
5. Annapoorna N, Rao GV, Reddy NS, Rambabu P, Rao KR. An increased risk of osteoporosis during acquired immunodeficiency syndrome. Int J Med Sci 2004; 1:152-64.
6. Mondy K, Tebas P. Emerging bone problems in patients infected with human immunodeficiency virus. Clin Infect Dis 2003; 36: S101-5. (Pubitemid 36408119)
7. Triant VA, Brown TT, Lee H, Grinspoon SK. Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large US healthcare system. J Clin Endocrinol Metab 2008; 93:3499-504.
8. Aronson N, McKaig R, Howard R, Hammock V, Hawkes C, Duncan W. Frequent decreased bone mineral density is seen in a predominantly African-American male HIV-infected patient cohort. Washington, DC: 45th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC, 2005.
9. Weintrob A, Fieberg A, Agan B, et al. Increasing age at HIV seroconversion from 18 to 40 years is associated with favorable virologic and immunologic responses to HAART. J Acquir Immune Defic Syndr 2008; 49:40-7.
10. Weintrob A, Grandits G, Agan B, et al. Virologic response differences between African Americans and European Americans initiating highly active antiretroviral therapy with equal access to care. J Acquir Immune Defic Syndr 2009; 52:574-80.
11. Tangpricha V, Pearce EN, Chen TC, Holick MF. Vitamin D insufficiency among free-living healthy young adults. Am J Med 2002; 112:659-62.
12. Munger K, Levin L, Hollis B, Howard N, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006; 296:2832-8. (Pubitemid 44969183)
13. DeVan ML, Bankson DD, Abadie JM. To what extent are free testosterone (FT) values reproducible between the two Washingtons, and can calculated FT be used in lieu of expensive direct measurements? Am J Clin Pathol 2008; 129:459-63.
14. -1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992; 41:1-19.
15. Hanley DA, Davison KS. Vitamin D insufficiency in North America. J Nutr 2005; 135:332-7. (Pubitemid 40194502)
16. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1994; 843:1-129.
17. Ibrahim JG. Incomplete data in generalized linear models. J Am Statist Assoc 1990; 85:765-9.
18. Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed. New York: Wiley, 2000.
19. Engelman CD, Fingerlin TE, Langefeld CD, et al. Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans. J Clin Endocrinol Metab 2008; 93:3381-8.
20. Ormesher B, Dhaliwal S, Nylen E, et al. Vitamin D deficiency is less common among HIV-infected African-American men than in a matched NHANES cohort. AIDS 2011; 25:1237-9.
21. Childs K, Welz T, Samarawickrama A, Post FA. Effects of vitamin D deficiency and combination antiretroviral therapy on bone in HIVpositive patients. AIDS 2012; 26:253-62.
22. Mueller NJ, Fux CA, Ledergerber B, et al. High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients. AIDS 2010; 24:1127-34.
23. Adeyemi OM, Agniel D, French AL, et al. Vitamin D deficiency in HIV-infected and un-infected women in the US. J Acquir Immune Defic Syndr 2011; 57:197-204.
24. Fox J, Peters B, Prakash M, Arribas J, Hill A, Moecklinghoff C. Improvement in vitamin D deficiency following antiretroviral regime change: Results from the MONET trial. AIDS Res Hum Retroviruses 2011; 27:29-34.
25. Yin M, Stein E. The effect of antiretrovirals on vitamin D. Clin Infect Dis 2011; 52:406-8.
26. Gerstner G, Damiano ML, Tom A, et al. Prevalence and risk factors associated with decreased bone mineral density in patients with haemophilia. Haemophilia 2009; 15:559-65.
27. Brown TT, Qaqish RB. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: A meta-Analytic review. AIDS 2006; 20:2165-74.
28. Bonjoch A, Figueras M, Estany C, et al. High prevalence of and progression to low bone mineral density in HIV-infected patients: A longitudinal cohort study. AIDS 2010; 24:2827-33.
29. Ramayo E, González-Moreno MP, Macías J, et al. Relationship between osteopenia, free testosterone, and vitamin D metabolite levels in HIV-infected patients with and without highly active antiretroviral therapy. AIDS Res Hum Retroviruses 2005; 21: 915-21.
30. Rodríguez M, Daniels B, Gunawardene S, Robbins GK. High frequency of vitamin D deficiency in ambulatory HIV-positive patients. AIDS Res Hum Retroviruses 2009; 25:9-14.
31. Keith JN, Nicholls J, Reed A, Kafer K, Miller GD. The prevalence of self-reported lactose intolerance and the consumption of dairy foods among African American adults are less than expected. J Natl Med Assoc 2011; 103:36-45.
32. Viard JP, Souberbielle JC, Kirk O, et al. Vitamin D and clinical disease progression in HIV infection: Results from the EuroSIDA study. AIDS 2011; 25:1305-15.
33. Autier P, Gandini S. Vitamin D supplementation and total mortality: A meta-Analysis of randomized controlled trials. Arch Intern Med 2007; 167:1730-7. (Pubitemid 47403059)
34. Cannell JJ, Vieth R, Umhau JC, et al. Epidemic influenza and vitamin D. Epidemiol Infect 2006; 134:1129-40.
35. Yamshchikov AV, Desai NS, Blumberg HM, Ziegler TR, Tangpricha V. Vitamin D for treatment and prevention of infectious diseases: A systematic review of randomized controlled trials. Endocr Pract 2009; 15:438-49.
36. Mehta S, Giovannucci E, Mugusi FM, et al. Vitamin D status of HIVinfected women and its association with HIV disease progression, anemia, and mortality. PLoS One 2010; 5:e8770.